Eagle Pharmaceuticals, Inc. to Present at Investor Conferences in June
Tweet
Share
E-mailGet Alerts EGRX Hot Sheet
Join SI Premium – FREE
WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)-- Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) announced today that management will present at two investor conferences in June as follows:
|
Conference: |
Jefferies 2017 Global Healthcare Conference |
|||||||
| Date: | Thursday, June 8, 2017 | |||||||
| Time: | 1:30 p.m. Eastern Daylight Time | |||||||
| Location: | Grand Hyatt New York, NYC | |||||||
|
Presenters: |
Scott Tarriff, Chief Executive Officer, and David Pernock, President and Chief Commercial Officer |
|||||||
|
Webcast: |
|
Conference: |
William Blair 37th Annual Growth Stock Conference |
|||||||
| Date: | Wednesday, June 14, 2017 | |||||||
| Time: | 1:20 p.m. Central Daylight Time | |||||||
| Location: | Four Seasons Hotel, Chicago | |||||||
|
Presenters: |
David Pernock, President and Chief Commercial Officer, and David Riggs, Executive Vice President of Administration |
|||||||
|
Webcast: |
||||||||
The presentations will be webcast live at the aforementioned time, and archived for 30 days thereafter, via the company’s website at www.eagleus.com, under the Investors Section.
About Eagle Pharmaceuticals, Inc.
Eagle is a specialty pharmaceutical company focused on developing and commercializing injectable products that address the shortcomings, as identified by physicians, pharmacists and other stakeholders, of existing commercially successful injectable products. Eagle’s strategy is to utilize the FDA's 505(b)(2) regulatory pathway. Additional information is available on the company’s website at www.eagleus.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170531006073/en/
Investor Relations for Eagle Pharmaceuticals, Inc:
Lisa M.
Wilson, 212-452-2793
[email protected]
Source: Eagle Pharmaceuticals, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies Starts Latigo Biotherapeutics (LTGO) at Buy
- Enovis Invests in Innovation with Binding Offer to Acquire eCential Robotics, a Leading Developer of Enabling Technologies and Surgical Robotics
- HealthTab™ Programme Expands Nationally Across England
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
William Blair, Jefferies & Co, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
